Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31606403 | 1.00 | SMN1; SMN2 (0.35) | SMN1; SMN2LMNAALDH1A1KDM4ERAB9A | |
| SCHEMBL22977708 | 0.90 | RAB9A (0.33) | SMN1; SMN2LMNAALDH1A1KDM4ERAB9A | |
| SCHEMBL22977712 | 0.90 | RAB9A (0.33) | SMN1; SMN2LMNAALDH1A1KDM4ERAB9A | |
| SCHEMBL31606376 | 0.90 | RAB9A (0.33) | SMN1; SMN2LMNAALDH1A1KDM4ERAB9A | |
| SCHEMBL31606385 | 0.90 | RAB9A (0.33) | SMN1; SMN2LMNAALDH1A1KDM4ERAB9A | |
| SCHEMBL31606378 | 0.90 | SMN1; SMN2 (0.31) | SMN1; SMN2LMNA | |
| SCHEMBL22977719 | 0.90 | SMN1; SMN2 (0.31) | SMN1; SMN2LMNA | |
| SCHEMBL22977706 | 0.77 | SMN1; SMN2 (0.33) | SMN1; SMN2LMNAALDH1A1KDM4ERAB9A | |
| SCHEMBL21178996 | 0.77 | SMN1; SMN2 (0.33) | SMN1; SMN2LMNAALDH1A1KDM4ERAB9A | |
| SCHEMBL22977717 | 0.70 | CNR1 (0.34) | SMN1; SMN2LMNAALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210045385-A1 | PYRIDAZINONE-SUBSTITUTED KETOXIMES AS HERBICIDES | FMC CORP (US) | 2021-02-18 | — | — | US | claimed |
| US-20260098020-A1 | HERBICIDAL PYRIMIDINYLMETHYL-SUBSTITUTED 1,2,4-TRIAZOLES | FMC CORP (US) | 2026-04-09 | — | — | US | disclosed |
| US-20210045385-A1 | PYRIDAZINONE-SUBSTITUTED KETOXIMES AS HERBICIDES | FMC CORP (US) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210045385-A1 | PYRIDAZINONE-SUBSTITUTED KETOXIMES AS HERBICIDES | CYP1A2, CYP1B1, CYP1A1 | SMN1; SMN2 4480/4885LMNA 3146/4885ALDH1A1 257/4885 |
| US-20260098020-A1 | HERBICIDAL PYRIMIDINYLMETHYL-SUBSTITUTED 1,2,4-TRIAZOLES | CBR3, CBR1, CNPY3 | SMN1; SMN2 4537/4885LMNA 2391/4885ALDH1A1 536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.